Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.225
Bid: 1.15
Ask: 1.30
Change: -0.025 (-2.00%)
Spread: 0.15 (13.043%)
Open: 1.25
High: 1.25
Low: 1.225
Prev. Close: 1.25
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

28 Feb 2023 07:00

RNS Number : 2109R
Chamberlin PLC
28 February 2023
 

28 February 2023

AIM: CMH

 

CHAMBERLIN PLC

("Chamberlin" or "the Company" or "the Group")

 

Interim Results

for the six months ended 30 November 2022

 

Chamberlin plc (AIM: CMH) is pleased to announce its interim results for the six months ended 30 November 2022 ("H1 2023").

 

Key Points

 

· Revenue of £10.5m (H1 2022: £8.0m), an increase of 32%

 

· Underlying loss before tax £0.3m (H1 2022: £0.1m)

 

· Continued strong growth at Petrel with significantly improved operating performance

 

Post Period

 

· Potential sale and leaseback for Walsall freehold site, subject to contract

 

 

Chairman, Keith Butler-Wheelhouse, commented: 

 

"All operating businesses within the Group are now operationally profitable, with new opportunities for growth continuing to emerge, the most significant being the newly reinvigorated Petrel".

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.

 

 

Enquiries

 

Chamberlin plc

Kevin Price, Chief Executive Officer

Alan Tomlinson, Finance Director

T: 01922 707100

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Katy Birkin

Stephen Keys

George Lawson

T: 020 7397 8900

Peterhouse Capital Limited (Joint Broker)

Lucy Williams

Duncan Vasey

 

T: 020 7469 0930

Chairman's Statement

 

Revenues in the first six months increased by 32% to £10.5m compared to £8.0m in the prior period, reflecting strong growth across all operations. Revenues in the second half of the year are expected to continue on a similar path, supported by strong order books at RDC and Petrel and the commencement of new contracts recently won by CHC, as previously announced. 

 

Operational performance of the Group in H1 2023 was impacted by inflationary cost pressures, primarily at CHC, with the underlying loss before tax increasing slightly to £0.3m (H1 2022: £0.1m), although these cost pressures have now been addressed through price increases and further cost savings. Despite these cost pressures, both Petrel and RDC delivered strong operating performances, with operating profit increasing by 78% and 11% respectively, compared with the prior period.

 

Petrel's new management team, led by divisional Managing Director Mark Pemberton, has overseen a substantial increase in operating performance. The team are now seeking to build on this strong base and have developed a strategy for Petrel that will involve entry into new export markets and sectors such as pharmaceutical and oil and gas. Petrel will continue to modernise and innovate to ensure it remains at the forefront of hazard lighting technology and meets evolving customer requirements.

 

In January 2023, Chamberlin completed a placing and subscription raising £650,000 to support the Group's working capital requirements as it enters a period of profitable growth. At that time, the Board stated that it was continuing to evaluate further opportunities to strengthen the balance sheet, including in relation to the Group's property assets. The Group is in discussions regarding a proposed sale and leaseback transaction at its Walsall freehold property which would include a proportion of any realised funds to be utilised to further reduce the Company's pension fund deficit. Whilst the freehold is currently under offer at £2.2m, Shareholders should note that this is subject to contract and there can be no certainty that this transaction will be completed. Further announcements will be made, as appropriate.

 

Outlook

 

The Group continues to go from strength to strength and is performing in line with market expectations.

 

The Board believes that Chamberlin is now entering a period of continuous growth with all businesses profitable in January 2023 for the first time in many years and supporting the Board's expectations that Group profits in FY 2023 will be second half weighted.

 

 

Keith Butler-Wheelhouse

Chairman

 

 

 

 

Consolidated Income Statement

for the six months ended 30 November 2022

 

 

 

 

 

Note

Unauditedsix months ended30 November 2022

Unauditedsix months ended30 November 2021

Year ended31 May 2022

Underlying

# Non-underlying

Total

Underlying

# Non-underlying

Total

Underlying

# Non-underlying

Total

£000

£000

£000

£000

£000

£000

£000

£000

£000

Revenue

2

10,544

-

10,544

8,013

-

8,013

16,836

-

16,836

Cost of sales

(9,104)

-

(9,104)

(6,636)

-

(6,636)

(15,038)

-

(15,038)

Gross profit

1,440

-

1,440

1,377

-

1,377

1,798

-

1,798

Other operating expenses

7

(1,583)

(140)

(1,723)

(1,409)

50

(1,359)

(2,501)

505

(1,996)

Operating (loss)/profit

(143)

(140)

(283)

(32)

50

18

(703)

505

(198)

Interest receivable

Finance costs

 

3

47

(231)

-

-

47

(231)

-

(104)

-

-

-

(104)

26

(337)

-

-

26

(337)

(Loss)/profit before tax

(327)

(140)

(467)

(136)

50

(86)

(1,014)

505

(509)

Tax credit/(expense)

4

186

-

186

188

-

188

581

-

581

Profit/(loss) for the period attributable to equity holders of the Parent Company

(141)

(140)

(281)

52

50

102

(433)

505

72

 

 

Earnings/(loss) per share:

 

Basic

5

(0.1)p

(0.2)p

(0.3)p

0.1p

-

0.1p

(0.5)p

0.6p

0.1p

Diluted

(0.1)p

(0.2)p

(0.3)p

0.1p

-

0.1p

(0.5)p

0.6p

0.1p

# Non-underlying items include restructuring costs, hedge ineffectiveness, impairment of assets, dilapidation costs and share-based payment costs together with the associated tax impact.

 

 

 

Consolidated Statement of Comprehensive Income

for the six months ended 30 November 2022

 

 

 

Unauditedsix months ended30 November2022

Unauditedsix months ended30 November2021

Year ended31 May2022

£000

£000

£000

(Loss)/profit for the period

(281)

102

72

Other comprehensive income

Gain on revaluation of property, plant & equipment

-

-

1,003

Movements in fair value of cash flow hedges taken to other comprehensive income

3

(69)

(158)

Deferred tax on movements in cash flow hedges

(1)

17

40

Net other comprehensive income/(expense) that may be recycled to profit and loss

2

(52)

885

 

Re-measurement (losses)/gains on pension scheme assets and liabilities

 

(880)

 

(42)

 

332

Deferred tax on re-measurement (losses)/ gains on pension assets and liabilities

 

167

8

(63)

Net other comprehensive (expense)/ income that will not be reclassified to profit and loss

(713)

(34)

269

 

Other comprehensive (expense)/income for the period net of tax

 

(711)

(86)

1,154

Total comprehensive (expense)/income for the period attributable to equity holders of the Parent Company

 

(992)

 

16

 

1,226

 

 

 

Consolidated Balance Sheet

at 30 November 2022

 

 

 

Unaudited30 November2022

Unaudited30 November2021

31 May2022

£000

£000

£000

Non-current assets

Property, plant and equipment

3,525

2,515

3,506

Intangible assets

263

244

283

Deferred tax assets

1,621

1,402

1,434

Defined benefit pension scheme surplus

-

-

64

5,409

4,161

5,287

Current assets

Inventories

3,449

2,264

3,143

Trade and other receivables

4,955

3,160

4,303

Cash at bank

124

6

-

8,528

5,430

7,446

Total assets

13,937

9,591

12,733

Current liabilities

  Financial liabilities

3,873

2,573

2,877

Trade and other payables

7,281

6,429

6,475

11,154

9,002

9,352

Non-current liabilities

Financial liabilities

1,814

1,007

2,097

Deferred tax liabilities

60

107

70

Provisions

806

890

806

Defined benefit pension scheme deficit

634

1,077

-

3,314

3,081

2,973

Total liabilities

14,468

12,083

12,325

Capital and reserves

Share capital

2,088

2,051

2,087

Share premium

6,332

4,720

6,308

Capital redemption reserve

109

109

109

Revaluation reserve

1,003

-

1,003

Hedging reserve

102

166

100

Retained earnings

(10,165)

(9,538)

(9,199)

Total equity

(531)

(2,492)

408

Total equity and liabilities

13,937

9,591

12,733

 

 Consolidated Cash Flow Statement

for the six months ended 30 November 2022

Unauditedsix months ended30 November2022

Unauditedsix months ended30 November2021

Year ended31 May2022

£000

£000

£000

Operating activities

Loss for the period before tax

(467)

(86)

(509)

Adjustments for:

Interest receivable

Net finance costs

(47)

231

-

104

(26)

337

Impairment charge on property, plant and equipment, inventory and receivables

 

-

 

(84)

 

(498)

Dilapidations provision

-

-

(84)

Depreciation of property, plant and equipment

186

176

324

Amortisation of intangible assets

20

23

24

Profit on disposal of property plant and equipment

Foreign exchange rate movements

-

(6)

-

(1)

(66)

(1)

Share-based payments

34

34

67

Defined benefit pension contributions paid

(180)

(165)

(935)

(Increase) in inventories

(307)

(566)

(945)

(Increase)/decrease in receivables

(796)

779

(168)

Increase/(decrease) in payables

830

(1,688)

(1,557)

Corporation tax received

306

-

-

Net cash outflow from operating activities

(196)

(1,474)

(4,037)

Investing activities

Purchase of property, plant and equipment

(205)

(197)

(520)

Purchase of software

-

(4)

(20)

Development costs

Disposal of property, plant and equipment

-

-

-

-

(24)

1,189

Net cash outflow from investing activities

(205)

(201)

625

Financing activities

Interest received

47

-

26

Interest paid

(233)

(94)

(324)

Net invoice finance drawdown

1,048

1,011

1,585

New share capital issued

-

-

1,624

Finance lease payments

(337)

(274)

(537)

 

Net cash inflow from financing activities

 

525

 

643

 

2,374

Net increase/(decrease) in cash and cash equivalents

 

124

 

(1,032)

 

(1,038)

Cash and cash equivalents at the start of the period

Impact of foreign exchange rate movements

 

-

-

 

1,038

-

 

1,038

-

 

Cash and cash equivalents at the end of the period

 

 

124

 

6

 

-

Cash and cash equivalents compromise:

 

Cash at bank

 

124

 

6

 

-

 

 

 

 

 

Consolidated Statement of Changes in Equity

for the six months ended 30 November 2022

Share capital

Share premium

Capital redemption reserve

Hedging reserve

 

Revaluation reserve

Retained earnings

Total equity

£000

£000

£000

£000

£000

£000

£000

At 1 June 2021

2,051

4,720

109

218

-

(9,664)

(2,566)

Profit for the period

-

-

-

-

-

102

102

Other comprehensive income/(expense) for the period net of tax

-

-

-

(52)

-

(34)

(86)

Total comprehensive income/(expense)

-

-

-

(52)

-

68

16

Share-based payments

-

-

-

-

-

34

34

Deferred tax on share-based payments

-

-

-

-

-

24

24

Total of transactions with shareholders

-

-

-

-

 

-

58

58

At 30 November 2021

2,051

4,720

109

166

 

-

(9,538)

(2,492)

Loss for the period

-

-

-

-

(30)

(30)

Other comprehensive income for the period net of tax

-

-

-

(66)

 

1,003

303

1,240

Total comprehensive income/(expense)

-

-

-

(66)

 

1,003

273

1,210

New share capital issued

36

1,588

-

-

 

-

-

1,624

Share-based payments

-

-

-

-

 

-

33

33

Deferred tax on share-based payments

-

-

-

-

 

-

33

33

Total of transactions with shareholders

36

1,588

-

-

 

-

66

1,690

At 1 June 2022

2,087

6,308

109

100

 

1,003

(9,199)

408

Loss for the period

-

-

-

-

 

-

(281)

(281)

Other comprehensive expense for the period net of tax

-

-

-

2

 

-

(713)

(711)

Total comprehensive (expense)/income

-

-

-

2

 

-

(994)

(992)

New share capital issued

1

24

-

-

 

-

 

-

25

Share-based payments

-

-

-

-

34

34

Deferred tax on share-based payments

-

-

-

-

(6)

(6)

Total of transactions with shareholders

1

24

-

-

 

-

28

53

At 30 November 2022

2,088

6,332

109

102

 

1,003

(10,165)

(531)

 

 

Notes to the Interim Financial statements

 

1 General information and accounting policies

 

The unaudited interim condensed consolidated financial statements do not comprise the Group's statutory accounts as defined by section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 May 2022 were approved by the Board of Directors on 4 November 2022 and filed at Companies House. The auditor's report on those accounts was unqualified but contained an emphasis of matter paragraph relating to a material uncertainty regarding going concern.

 

Basis of preparation

 

The Group's financial statements have been prepared in accordance with International Accounting Standards in conformity with the requirements of the Companies Act 2006.

 

The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with AIM Rules issued by the London Stock Exchange.

 

Accounting policies

 

The principal accounting policies applied in preparing the interim Financial Statements comply with IFRS as adopted by the European Union and are consistent with the policies set out in the Annual Report and Accounts for the year ended 31 May 2022.

 

No new standards or interpretations issued since 31 May 2022 have had a material impact on the financial statements of the Group.

 

Going concern

The Director's assessment of going concern is based on the Group's detailed forecast for the three years ending 31 May 2023, 31 May 2024 and 31 May 2025, which reflect the Director's view of the most likely trading conditions. In November 2022, the Group secured an increase to its invoice finance facilities from £3.5m to £4.5m and the forecasts indicate that these bank facilities are expected to remain adequate.

 

The forecasts include revenue growth and margin improvement assumptions across all of the Group's businesses. At Chamberlin and Hill Castings, these assumptions include an improvement in automotive volumes as this sector recovers from the backlog of passenger vehicle orders arising from the shortage of vital electronic and other components in the last 18 months, modest growth from fitness equipment and cookware products and diversification into new markets. At RDC, the forecasts assume that revenue and margin growth will be achieved from the investment being made in the expansion of its capacity and the ability to manufacture and sell a wider range of products using new materials. At Petrel, revenue and margin growth assumptions are based on the introduction of new products, including the use of new technology, and services, including warranty, inspection and maintenance.

 

The Directors have applied reasonably foreseeable downside sensitivities to the forecast, including sales growth and margin improvement at Chamberlin and Hill Castings is 40% and 20% lower than expectations respectively, sales growth and margin improvement at RDC are both 20% lower than expectations and sales growth and margin at Petrel are 20% and 10% lower than expectations respectively. Furthermore, the Group is reliant on an invoice finance facility to fund its working capital needs. The renewal of the facility at the next annual review in March 2023 cannot be guaranteed, although there are no indications at the date of the approval of the financial statements that a renewal with the existing provider would not be granted or that alternative providers could not be found. In addition, the Directors have assumed that deferred settlement terms will be agreed with HMRC in relation to PAYE arrears of £1.5m for one subsidiary in the Group that have arisen in the period since the announcement by BorgWarner, having already agreed deferred settlement terms with HMRC for two subsidiaries.

 

As a consequence, after making enquiries, the Directors have an expectation that, in the circumstances of the reasonably foreseeable downside scenarios described above, the Group and Company have adequate resources to continue in operational existence for the foreseeable future.

 

However, the rate at which revenue growth and margin improvement can be achieved during a potentially future recessionary period and uncertain global trading conditions is difficult to predict. Furthermore, the ability to renew or source alternative invoice finance facilities or to agree deferred settlement terms with HMRC results in material uncertainty, which may cast significant doubt over the ability of the Group and the Company to realise its assets and discharge its liabilities in the normal course of business and hence continue as a going concern.

 

The Directors continue to adopt the going concern basis, whilst recognising there is material uncertainty relating to the above matters.

 

2 Segmental analysis

 

For management purposes, the Group is organised into two operating divisions: Foundries and Engineering. The operating segments reporting format reflects the Group's management and internal reporting structures for the Chief Operating Decision Maker.

 

Revenue

Operating (loss)/ profit

Unaudited

 six months

ended

30 November

2022

 

£000

Unaudited

six months

ended

30 November

2021

 

£000

 

Year ended

31 May

2022

 

£000

Unaudited

six months

ended

30 November

2022

 

£000

Unaudited

six months

ended

30 November

2021

 

£000

 

Year ended

31 May

2022

 

£000

Foundries

8,600

6,469

13,604

(9)

120

(463)

Engineering

1,944

1,544

3,232

343

193

535

Segmental results

10,544

8,013

16,836

334

313

72

Shared costs

(477)

(345)

(775)

Non-underlying items (Note 7)

(140)

50

505

Net finance costs

(184)

(104)

(311)

Loss before tax

(467)

(86)

(509)

 

The Foundries segment is a supplier of iron castings, in raw or machined form, to a variety of industrial customers who incorporate the castings into their own products or carry out further machining or assembly operations on the castings before selling them on. The Engineering segment provides manufactured hazardous area lighting products to distributors and end-users.

 

Financing and income tax are managed on a Group basis and are not allocated to operating segments.

 

 

3 Finance costs

Unauditedsix months ended30 November

2022

Unauditedsix months ended30 November

2021

Year ended31 May

2022

£000

£000

£000

Interest on bank financing facilities

(132)

(23)

(94)

Interest expense on lease liabilities and other interest payable

(101)

(71)

(230)

Net interest on defined benefit pension liability

2

(10)

(13)

(231)

(104)

(337)

 

   

 

 

 

 

4 Income tax expense

 

An estimated effective rate of tax for the six months to 30 November 2022 of 39.8% (30 November 2021: 218.6%) has been used in these interim statements. This rate differs to the standard corporation tax rate of 19% due primarily due to the recognition of a deferred tax asset on certain trading losses, accelerated capital allowances and short-term timing differences. The corporation tax rate remained at 19% for the year ended 31 May 2022.

 

5 Earnings/(loss) per share

 

The calculation of earnings/(loss) per share is based on the profit/(loss) attributable to shareholders and the weighted average number of ordinary shares in issue. In calculating the diluted loss per share, adjustment has been made for the dilutive effect of outstanding share options where applicable. Underlying earnings/(loss) per share, which excludes non-underlying items and the related tax thereon as disclosed in Note 7, as analysed below, has been disclosed as the Directors believe this allows a better assessment of the underlying trading performance of the Group.

 

Unaudited

six months ended

30 November

2022

Unaudited

six months ended

30 November

2021

Year ended

31 May

2022

£000

£000

£000

(Loss)/profit after tax for basic earnings per share

(281)

102

72

Non-underlying operating items

140

(50)

(505)

Taxation effect of the above

-

-

-

 

(Loss)/profit for underlying earnings per share

 

(141)

 

52

 

(433)

 

 

 

 

Unaudited

six months ended

30 November

2022

Unaudited

six months ended

30 November

2021

Year ended

31 May

2022

000

000

000

Weighted average number of ordinary shares

105,625

69,625

79,488

Adjustment to reflect dilutive shares under option

3,581

3,581

3,581

 

Diluted weighted average number of ordinary shares

 

109,206

 

73,206

 

83,069

 

There is no adjustment for the shares under option in the diluted loss per share calculation for the six months ended 30 November 2022 as they are required to be excluded from the weighted average number of shares as they are anti-dilutive.

 

 

6 Pensions

 

The Group operates a defined benefit pension scheme and a defined contribution pension scheme on behalf of its employees. For the defined contribution scheme, contributions paid in the period are charged to the income statement. For the defined benefit scheme, actuarial calculations are performed in accordance with IAS 19 in order to arrive at the amounts to be charged in the income statement and recognised in the statement of comprehensive income. The defined benefit scheme is closed to new entrants and future accrual.

 

Under IAS 19, the Group recognises all movements in the actuarial funding position of the scheme in each period. This is likely to lead to volatility in shareholders' equity from period to period.

 

The IAS 19 figures are based on a number of actuarial assumptions as set out below, which the actuaries have confirmed they consider appropriate. The projected unit credit actuarial cost method has been used in the actuarial calculations.

 

30 November

2022

30 November

2021

31 May

2022

Salary increases

n/a

n/a

n/a

Pension increases (post 1997)

3.1%

3.2%

3.4%

Discount rate

4.5%

1.6%

3.4%

Inflation assumption - RPI

3.1%

3.3%

3.5%

Inflation assumption - CPI

2.4%

2.6%

2.8%

 

The demographic assumptions used for 30 November 2022 were the same as those used at 31 May 2022, and were based on the last full actuarial valuation performed as at 31 March 2019. The contributions expected to be paid during the year to 31 May 2023 are £362,000. The triennial valuation as at 31 March 2022 is currently in progress.

 

The defined benefit scheme funding has changed under IAS 19 as follows:

 

 

 

Funding status

Unaudited

30 November

2022

£000

Unaudited

 30 November

2021

£000

 

31 May

2022

£000

Scheme assets at end of period

 

11,924

16,156

14,024

Benefit obligations at end of period

(12,558)

(17,233)

(13,960)

(Deficit)/surplus in scheme

(634)

(1,077)

64

Related deferred tax asset/(liability)

159

269

(16)

Net pension (liability)/asset

(475)

(808)

48

The change in the net pension liability since 31 May 2022 is mainly due to negative investment returns arising from a fall in the market value of scheme assets partially offset by a reduction in the value of liabilities as a consequence of an increase in bond yields increasing the discount rate.

 

7 Non-underlying items

 

 

 

Unaudited

six months ended

30 November

2022

Unaudited

six months ended

30 November

2021

Year ended

31 May

2022

£000

£000

£000

Group reorganisation

106

-

-

Additional liability from customer claim relating to disposal of Exidor Limited

-

-

10

 

Impairment reversal relating to inventory and receivables

-

(84)

(498)

Dilapidations provision release

-

-

(84)

Share-based payment charge

34

34

67

Non-underlying operating costs/(income)

140

(50)

(505)

Taxation

- tax effect of non-underlying costs

-

-

-

140

(50)

(505)

 

In the six months ended 30 November 2022, the Group undertook a restructure of the senior management team at Petrel leading to redundancy and other associated costs of £106,000.

 

 

 

 

 

 

 

8 Net debt

 

 

 

Unaudited

30 November

2022

Unaudited

30 November

2021

 

31 May

2022

£000

£000

£000

Financial liabilities

Net cash

(124)

(6)

-

Lease liabilities

580

1,065

634

Invoice finance liability

3,293

1,508

2,243

Net debt due in less than one year

3,749

2,567

2,877

Lease liabilities due in more than one year

1,814

1,007

2,097

Net debt

5,563

3,574

4,974

 

 

 

9 Interim report

 

This interim results statement is available on the Group's website, www.chamberlin.co.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR TRMPTMTJTBIJ
Date   Source Headline
22nd Apr 20247:00 amRNSHolding(s) in Company
16th Apr 202410:43 amRNSHolding(s) in Company
10th Apr 20247:00 amRNSTrading Update
5th Apr 20247:00 amRNSBoard Changes
3rd Apr 20244:12 pmRNSHolding(s) in Company
27th Feb 20241:24 pmRNSHolding(s) in Company
22nd Feb 20247:00 amRNSCompletion of Sale of Petrel Limited
21st Feb 202412:01 pmRNSSale of Petrel Limited
21st Feb 202412:00 pmRNSInterim Results
18th Jan 20243:34 pmRNSHolding(s) in Company
16th Jan 20241:20 pmRNSHolding(s) in Company
11th Jan 20246:26 pmRNSHolding(s) in Company
10th Jan 20245:12 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSPlacing and Subscription
3rd Jan 20242:41 pmRNSResult of AGM and Trading Update
15th Dec 20237:00 amRNSCorporate Update
30th Nov 20231:40 pmRNSFinal Results
28th Nov 20235:00 pmRNSHolding(s) in Company
24th Oct 20234:22 pmRNSChange of Nominated Adviser and Joint Broker
18th Oct 20232:14 pmRNSHolding(s) in Company
27th Jul 20232:00 pmRNSGrant of Share Options
24th Jul 202310:17 amRNSDirector/PDMR Shareholding
22nd Jun 20232:03 pmRNSMajor Contract Win
8th Jun 20237:00 amRNSHolding(s) in Company
26th May 20237:00 amRNSPlacing and Subscription
2nd May 20233:42 pmRNSSale and Leaseback of Walsall Property
28th Feb 20237:00 amRNSHalf-year Report
2nd Feb 20234:14 pmRNSHolding(s) in Company
1st Feb 20235:24 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSHolding(s) in Company
26th Jan 202311:53 amRNSPlacing and Subscription
19th Dec 202211:00 amRNSHolding(s) in Company
16th Dec 20221:49 pmRNSCorporate Update
30th Nov 202211:37 amRNSResult of AGM
30th Nov 20227:00 amRNSAGM Statement and Trading Update
21st Nov 20222:44 pmEQSChamberlin PLC 'left no stone unturned' during return to profit
7th Nov 20225:31 pmRNSPosting of Annual Report and Notice of AGM
4th Nov 202212:23 pmRNSFinal Results
31st Oct 202211:32 amRNSAnnouncement re: Full year results
29th Sep 20227:00 amRNSAnnouncement re: Full year results
29th Jul 20227:00 amRNSIssue of Equity and Director/PDMR Shareholding
25th Jul 20225:30 pmRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSHolding(s) in Company
8th Jul 20225:20 pmRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSFull Year Trading Update and Notice of Results
8th Jun 20229:42 amRNSDirector/PDMR Shareholding
5th May 20221:13 pmRNSSale and Leaseback of RDC Property
25th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20222:30 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.